These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23529454)

  • 1. 'Just a repeat' - When drug monitoring is indicated.
    Lucas C; Donovan P
    Aust Fam Physician; 2013; 42(1-2):18-22. PubMed ID: 23529454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic monitoring of digoxin and antiepileptic drugs in Egypt and Saudi Arabia.
    EL Desoky ES; AL-Ghamdi HA; Halaby FH; Al-Beshri M
    Ther Drug Monit; 2003 Apr; 25(2):211-4. PubMed ID: 12657916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of requests for serum digoxin concentrations: experience from an Australian regional health service.
    Ellington C; Grgurinovich N; Miners JO; Mangoni AA
    Br J Clin Pharmacol; 2007 May; 63(5):623-7. PubMed ID: 17073890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin therapeutic drug monitoring: an audit and review.
    Sidwell A; Barclay M; Begg E; Moore G
    N Z Med J; 2003 Dec; 116(1187):U708. PubMed ID: 14752536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic monitoring of antiepileptic drugs: a comparison between a Czech and a Swedish University Hospital.
    Koristkova B; Bergman U; Grundmann M; Brozmanova H; Sjöqvist F
    Ther Drug Monit; 2006 Oct; 28(5):594-8. PubMed ID: 17038871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monitoring serum levels of new antiepileptics].
    Armijo JA; Adín-Ibarra J; Sánchez-Baglietto N; Vega-Gil N
    Rev Neurol; 2002 Sep; 35 Suppl 1():S116-34. PubMed ID: 12373664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring of lithium in patients with bipolar affective disorder: experiences from a tertiary care hospital in India.
    Sharma S; Joshi S; Chadda RK
    Am J Ther; 2009; 16(5):393-7. PubMed ID: 19262359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance characteristics of four immunoassays for antiepileptic drugs on the IMMULITE 2000 automated analyzer.
    Frank EL; Schwarz EL; Juenke J; Annesley TM; Roberts WL
    Am J Clin Pathol; 2002 Jul; 118(1):124-31. PubMed ID: 12109846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capillary electrophoresis for therapeutic drug monitoring of antiepileptics.
    Kataoka Y; Makino K; Oishi R
    Electrophoresis; 1998 Nov; 19(16-17):2856-60. PubMed ID: 9870380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The practice of digoxin therapeutic drug monitoring.
    Barclay M; Begg E
    N Z Med J; 2003 Dec; 116(1187):U704. PubMed ID: 14752532
    [No Abstract]   [Full Text] [Related]  

  • 12. [Digoxin].
    Yamamoto K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():403-5. PubMed ID: 15658349
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of combination therapy on the plasma concentrations of traditional antiepileptics: a retrospective study.
    Sirmagul B; Atli O; Ilgin S
    Hum Exp Toxicol; 2012 Oct; 31(10):971-80. PubMed ID: 22588177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of drugs with a narrow therapeutic range in ambulatory care.
    Raebel MA; Carroll NM; Andrade SE; Chester EA; Lafata JE; Feldstein A; Gunter MJ; Nelson WW; Simon SR; Chan KA; Davis RL; Platt R
    Am J Manag Care; 2006 May; 12(5):268-74. PubMed ID: 16686584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suspected DLIS interference in the dimension DGNA digoxin assay method and the clinical application of the revised digoxin target range.
    Morris RG; Jones TE; Goldsworthy SJ; Wagner TJ; Ho H; Horowitz JD
    Ther Drug Monit; 2006 Jun; 28(3):454-7. PubMed ID: 16778733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practice-oriented quality specifications for therapeutic drug monitoring.
    Pauwels S; Vermeersch P; Desmet K; Vanstapel F
    Clin Chem; 2014 Mar; 60(3):559-60. PubMed ID: 24305686
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of plantain on therapeutic drug monitoring of digoxin and thirteen other common drugs.
    Dasgupta A; Davis B; Wells A
    Ann Clin Biochem; 2006 May; 43(Pt 3):223-5. PubMed ID: 16704760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The limitations of routine total digoxin immunoassay in patients with advanced chronic kidney disease.
    Sharma R; Guy M; Rudenski A; Lamerton E; Kalra PA
    QJM; 2009 Oct; 102(10):747-50. PubMed ID: 19602599
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of therapeutic drug monitoring of antiepileptic drugs.
    Irshaid YM; Hamdi AA; Al Homrany M
    Int J Clin Pharmacol Ther; 2003 Mar; 41(3):126-31. PubMed ID: 12665161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desirable standards of performance for therapeutic drug monitoring.
    Fraser CG
    Clin Chem; 1987 Mar; 33(3):387-9. PubMed ID: 3815803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.